×
About 4 results

ALLMedicine™ Anklyosing Spondylitis Center

Research & Reviews  1 results

Therapeutic controversies: tumor necrosis factor α inhibitors in ankylosing spondylitis.
https://doi.org/10.1016/j.rdc.2012.08.004
Rheumatic Diseases Clinics of North America; Song IH, Maksymowych WP

Oct 22nd, 2012 - Tumor necrosis factor α inhibitors (TNF blockers) have revolutionized the treatment of patients with anklyosing spondylitis. Despite clinical efficacy, there are questions and controversies treating rheumatologists face, which this review discusse...

see more →

Clinicaltrials.gov  2 results

In Spine Disease, Family Also at Risk
https://www.medpagetoday.com/rheumatology/generalrheumatology/58272

Jun 2nd, 2016 - Action Points Note that this cross-sectional analysis of first-degree relatives of individuals with anklyosing spondylitis found that a significant percentage had spondyloarthropathy. Be aware that this prevalence is slightly higher than prior stu...

Therapeutic controversies: tumor necrosis factor α inhibitors in ankylosing spondylitis.
https://doi.org/10.1016/j.rdc.2012.08.004
Rheumatic Diseases Clinics of North America; Song IH, Maksymowych WP

Oct 22nd, 2012 - Tumor necrosis factor α inhibitors (TNF blockers) have revolutionized the treatment of patients with anklyosing spondylitis. Despite clinical efficacy, there are questions and controversies treating rheumatologists face, which this review discusse...

see more →

News  1 results

In Spine Disease, Family Also at Risk
https://www.medpagetoday.com/rheumatology/generalrheumatology/58272

Jun 2nd, 2016 - Action Points Note that this cross-sectional analysis of first-degree relatives of individuals with anklyosing spondylitis found that a significant percentage had spondyloarthropathy. Be aware that this prevalence is slightly higher than prior stu...

see more →